Drug Profile
SM 20550
Alternative Names: SM-20550Latest Information Update: 01 Aug 2007
Price :
$50
*
At a glance
- Originator Sumitomo Pharmaceuticals
- Class Amidines; Anti-ischaemics; Antiarrhythmics; Cardiotonics; Indoles; Small molecules
- Mechanism of Action Sodium hydrogen antiporter inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Ischaemic heart disorders
Most Recent Events
- 05 Apr 2001 A preclinical study has been added to the Ischaemic Heart Disease pharmacodynamics section
- 22 Mar 1999 Two preclinical studies have been added to the Ischaemic Heart Disease pharmacodynamics section ,
- 24 Feb 1998 A preclinical study has been added to the Ischaemic Heart Disease pharmacodynamics section